Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04160065
Title Immunotherapy With IFx-Hu2.0 Vaccine for Advanced MCC or cSCC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Morphogenesis, Inc.
Indications

skin squamous cell carcinoma

Merkel cell carcinoma

Therapies

IFx-Hu2.0

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.